ImmuneOnco Biopharmaceuticals Shanghai Inc
F:R9Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ImmuneOnco Biopharmaceuticals Shanghai Inc
F:R9Z
|
CN |
|
T
|
Transcontinental Inc
OTC:TCLCF
|
CA |
|
Cradle Resources Ltd
F:329
|
AU |
|
B
|
Benchmark Holdings PLC
F:31B
|
UK |
|
Thesis Gold Inc
F:0110
|
CA |
|
Group Eleven Resources Corp
F:3GE
|
CA |
|
DigitalBridge Group Inc
F:6CL
|
US |
|
C
|
China Health Group Inc
F:VNL1
|
CN |
|
T
|
Total Telcom Inc
OTC:TTLTF
|
CA |
|
Shinko Electric Industries Co Ltd
OTC:SHEGF
|
JP |
|
Kuangchi Science Ltd
F:92N0
|
HK |
|
RHI Magnesita NV
OTC:RMGNF
|
AT |
|
LAVA Therapeutics NV
F:4PKB
|
NL |
|
United Arrows Ltd
OTC:UTDAY
|
JP |
|
Pigeon Corp
OTC:PGENY
|
JP |
|
Belships ASA
F:NS6
|
NO |
|
Transcontinental Inc
F:53L
|
CA |
|
Workman Co Ltd
OTC:WKISF
|
JP |
Bankruptcy Probability
ImmuneOnco Biopharmaceuticals Shanghai Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ImmuneOnco Biopharmaceuticals Shanghai Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
I
|
ImmuneOnco Biopharmaceuticals Shanghai Inc
HKEX:1541
|
3.1B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
456.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ImmuneOnco Biopharmaceuticals Shanghai Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ImmuneOnco Biopharmaceuticals Shanghai Inc has total debt of 32.7m CNY. This includes both short-term (0 CNY) and long-term (32.7m CNY) debt.
You can find a full breakdown on its Balance Sheet.
